Journal of Alzheimer s Disease · 2017 · 168 citations · 49 references
MedicineNeurologyNeuroscienceAgingDementiaNeurodegenerationAlzheimer DiseaseCognitive AgingIron MetabolismNeurodegenerative DiseasesNeurodegenerative DisordersNeuropathology Of AgingAge-sex DistributionAlzheimer Disease Tau PathologyAmyloid Beta PlaquesAmyloid PlaquesBraak StagingHistochemical MarkersHistochemical MicroscopyIron Distribution
Abnormal iron distribution in the isocortex is increasingly recognized as an in vivo marker for Alzheimer's disease (AD). However, the contribution of iron accumulation to the AD pathology is still poorly understood. In this study, we investigated: 1) frontal cortical iron distribution in AD and normal aging and 2) the relation between iron distribution and degree of AD pathology. We used formalin fixed paraffin embedded frontal cortex from 10 AD patients, 10 elder, 10 middle aged, and 10 young controls and visualized iron with a modified Perl's histochemical procedure. AD and elderly subjects were not different with respect to age and sex distribution. Iron distribution in the frontal cortex was not affected by normal aging but was clearly different between AD and controls. AD showed accumulation of iron in plaques, activated microglia, and, in the most severe cases, in the mid-cortical layers along myelinated fibers. The degree of altered iron accumulations was correlated to the amount of amyloid-β plaques and tau pathology in the same block, as well as to Braak stage (p < 0.001). AD and normal aging show different iron and myelin distribution in frontal cortex. These changes appear to occur after the development of the AD pathological hallmarks. These findings may help the interpretation of high resolution in vivo MRI and suggest the potential of using changes in iron-based MRI contrast to indirectly determine the degree of AD pathology in the frontal cortex.
49
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack, David S. Knopman, William J. Jagust et al. · The Lancet Neurology · 2009 · 4.8K citations · Full text
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
William E. Klunk, Henry Engler, Agneta Nordberg et al. · Annals of Neurology · 2004 · 4.5K citations
Medicine, Neurology, Neuroscience +15
The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods
Clifford R. Jack, Matt A. Bernstein, Nick C. Fox et al. · Journal of Magnetic Resonance Imaging · 2008 · 4.4K citations · Full text
Medicine, Neurology, Neuroscience +17
Copper, iron and zinc in Alzheimer's disease senile plaques
Mark A. Lovell, J. David Robertson, W.J. Teesdale et al. · Journal of the Neurological Sciences · 1998 · 2.1K citations
Implementing a Class of Permutation Tests: The<b>coin</b>Package
Torsten Hothorn, Kurt Hornik, Mark A. van de Wiel et al. · Journal of Statistical Software · 2008 · 1.5K citations · Full text